Schwedhelm Edzard, Maas Renke, Tan-Andresen Jing, Schulze Friedrich, Riederer Ulrich, Böger Rainer H
Institute of Experimental and Clinical Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Germany.
J Chromatogr B Analyt Technol Biomed Life Sci. 2007 May 15;851(1-2):211-9. doi: 10.1016/j.jchromb.2006.11.052. Epub 2006 Dec 27.
The balance between nitric oxide (NO) and vasoconstrictors like endothelin is essential for vascular tone and endothelial function. L-Arginine is converted to NO and L-citrulline by NO synthase (NOS). Asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) are endogenous inhibitors of NO formation. ADMA is degraded by dimethylamino dimethylhydrolases (DDAHs), while SDMA is exclusively eliminated by the kidney. In the present article we report a LC-tandem MS method for the simultaneous determination of arginine, ADMA, and SDMA in plasma. This method is designed for high sample throughput of only 20-mul aliquots of human or mouse plasma. The analysis time is reduced to 1.6 min by LC-tandem MS electrospray ionisation (ESI) in the positive mode. The mean plasma levels of l-arginine, ADMA, and SDMA were 74+/-19 (SD), 0.46+/-0.09, and 0.37+/-0.07 microM in healthy humans (n=85), respectively, and 44+/-14, 0.72+/-0.23, and 0.19+/-0.06 microM in C57BL/6 mice. Also, the molar ratios of arginine to ADMA were different in man and mice, i.e. 166+/-50 and 85+/-22, respectively.
一氧化氮(NO)与内皮素等血管收缩剂之间的平衡对于血管张力和内皮功能至关重要。左旋精氨酸通过一氧化氮合酶(NOS)转化为NO和L-瓜氨酸。不对称二甲基精氨酸(ADMA)和对称二甲基精氨酸(SDMA)是NO生成的内源性抑制剂。ADMA由二甲基氨基二甲基水解酶(DDAHs)降解,而SDMA仅通过肾脏清除。在本文中,我们报告了一种用于同时测定血浆中精氨酸、ADMA和SDMA的液相色谱串联质谱法。该方法专为仅20微升人或小鼠血浆等分试样的高样本通量而设计。通过液相色谱串联质谱电喷雾电离(ESI)正模式,分析时间缩短至1.6分钟。健康人(n = 85)血浆中L-精氨酸、ADMA和SDMA的平均水平分别为74±19(标准差)、0.46±0.09和0.37±0.07微摩尔,C57BL/6小鼠中分别为44±14、0.72±0.23和0.19±0.06微摩尔。此外,人和小鼠中精氨酸与ADMA的摩尔比不同,分别为166±50和85±22。